Peptidyl-lysine methylation

pathway activity — cross-omics
GO:0018022Cross-omicsPROTEIN-MS → RNAPatientPairwise association · TCGA cohorts

Across TCGA patient cohorts, RNA activity of the Peptidyl-lysine methylation pathway is significantly associated with the RNA expression of multiple genes, with the OV cohort showing a particularly strong set of associations.

The most reproducible pathway-associated genes across cancer lineages are LIN9, EZH2, and HELLS, each associated with the pathway in up to 7 cancer types. Since the analysis shows associations rather than directional relationships, both pathway-to-partner and partner-to-pathway views are reported.

Each partner is linked to its corresponding Q-omics profile. The scatter plot shows the strongest association, Peptidyl-lysine methylation activity versus LIN9 in OV (Pearson r = 0.27).

Pathway-associated genes by consensus

Ranked by combined sampling and lineage consensus. X-score (pathway→partner) and Y-score (partner→pathway) are standardized regression coefficients; both directions are reported because the association is undirected. The reported p-values are derived from the association test.
LineagePartner geneX-scoreY-scorep(X)p(Y)Sampling consensusLineage consensus
OVLIN9 →+0.518+0.290.002<.00137
HNSCEZH2 →+0.762+0.336.004.00337
LSCCHELLS →+0.764+0.473<.001<.00137
GBMKIFC1 →+1.015+0.592<.001<.00137
HNSCNUF2 →+0.839+0.362.001<.00136
HNSCC1orf112 →+0.576+0.263<.001<.00136
Each partner links to its Q-omics profile. Showing the 6 strongest associations by consensus.

GO:0018022 vs LIN9 — OV

Per-sample scatter of Peptidyl-lysine methylation activity vs LIN9 in OV.

Explore this scatter interactively →

Exploration